Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Mr. Arthur Frederick RyanIndependent Director | -100.00 | 70.52k | 売り | 701.76 - 714.13 | 15.80k | -0.63% |
| 2026-04-01 | Mr. Arthur Frederick RyanIndependent Director | -100.00 | 77.73k | Automatic Disposition | 771.32 - 779.71 | 15.90k | -0.63% |
| 2026-03-02 | Mr. Arthur Frederick RyanIndependent Director | -100.00 | 78.55k | Automatic Disposition | 777.46 - 789.28 | 16.00k | -0.62% |
| 2026-02-19 | Dr. Huda Y. ZoghbiIndependent Director | -1.64k | 662.79k | Derivative Exercise and Sale | 376.69 - 790.00 | 0.00 | - |
| 2026-02-09 | Mr. Jason PitofskySenior VP & Controller | -1,000.00 | 284.97k | Derivative Exercise and Sale | 492.00 - 778.35 | 4.48k | - |
| 2026-02-09 | Mr. Jason PitofskySenior VP & Controller | -1.04k | 808.08k | Automatic Disposition | 778.35 - 785.72 | 4.48k | -18.77% |
| 2026-02-09 | Mr. Arthur Frederick RyanIndependent Director | -100.00 | 77.85k | Automatic Disposition | 775.63 - 787.82 | 16.10k | -0.62% |
| 2026-01-07 | Dr. Bonnie L. BasslerIndependent Director | -1.50k | 638.82k | Derivative Exercise and Sale | 374.12 - 800.00 | 0.00 | - |
| 2025-12-31 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | -28.57k | 22.06M | Derivative Exercise and Sale | 772.09 | 1.13M | - |
| 2025-12-31 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | -28.57k | 22.06M | Derivative Exercise and Sale | 772.09 | 687.98k | - |
| 2025-12-30 | Mr. George L. SingIndependent Director | 3.02k | 1.57M | Derivative Exercise and Retained Stock | 520.01 | 33.00k | 10.09% |
| 2025-12-30 | Mr. George L. SingIndependent Director | -6.19k | 1.57M | Derivative Exercise and Sale | 520.01 - 774.03 | 33.00k | - |
| 2025-12-09 | Mr. Daniel P. Van PlewExec. VP and GM of Industrial Operations & Product Supply | -2.55k | 1.79M | Sale to Issuer | 701.51 | 35.18k | -6.76% |
| 2025-12-09 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -4.23k | 2.97M | Sale to Issuer | 701.51 | 52.21k | -7.49% |
| 2025-12-09 | Ms. Marion E. McCourtExec. VP of Commercial | -1.02k | 716.24k | Sale to Issuer | 701.51 | 14.55k | -6.56% |
| 2025-12-09 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | 14.94k | 8.30M | Derivative Exercise and Retained Stock | 555.67 | 1.13M | 1.34% |
| 2025-12-09 | Dr. George D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman | -131.87k | 19.23M | Derivative Exercise and Sale | 555.67 - 701.51 | 1.13M | - |
| 2025-12-09 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | 17.58k | 9.77M | Derivative Exercise and Retained Stock | 555.67 | 687.98k | 2.62% |
| 2025-12-09 | Dr. Leonard S. SchleiferCo-Founder, President, CEO & Co-Chairman | -155.15k | 22.63M | Derivative Exercise and Sale | 555.67 - 701.51 | 687.98k | - |
| 2025-12-08 | Mr. Jason PitofskySenior VP & Controller | -989.00 | 705.10k | Sale to Issuer | 712.94 | 5.52k | -15.20% |
| 2025-12-08 | Mr. Daniel P. Van PlewExec. VP and GM of Industrial Operations & Product Supply | -1.91k | 1.36M | Sale to Issuer | 712.94 | 37.73k | -4.81% |
| 2025-12-08 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -1.70k | 1.21M | Sale to Issuer | 712.94 | 56.44k | -2.92% |
| 2025-12-08 | Ms. Marion E. McCourtExec. VP of Commercial | -1.34k | 952.49k | Sale to Issuer | 712.94 | 15.57k | -7.90% |
| 2025-12-08 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | -1.40k | 995.26k | Sale to Issuer | 712.94 | 42.32k | -3.19% |
| 2025-12-08 | Mr. Christopher R. FenimoreExec. VP of Finance & CFO | -992.00 | 707.24k | Sale to Issuer | 712.94 | 21.80k | -4.35% |
| 2025-11-20 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | 1.76k | 980.20k | Derivative Exercise and Retained Stock | 555.67 | 41.23k | 4.47% |
| 2025-11-20 | Mr. Joseph J. LaRosaExec. VP, General Counsel & Secretary | -12.69k | 2.30M | Derivative Exercise and Sale | 555.67 - 736.77 | 41.23k | - |
| 2025-11-20 | Dr. Bonnie L. BasslerIndependent Director | -760.00 | 287.74k | Derivative Exercise and Sale | 371.40 - 750.00 | 0.00 | - |
| 2025-11-07 | Mr. Jason PitofskySenior VP & Controller | -431.00 | 280.77k | 売り | 651.43 | 4.44k | -8.84% |
| 2025-10-30 | Ms. Christine Ann PoonLead Independent Director | 2.71k | 1.41M | Derivative Exercise and Retained Stock | 520.01 | 3.52k | 337.31% |
| 2025-10-29 | Ms. Christine Ann PoonLead Independent Director | -6.50k | 872.68k | Derivative Exercise and Sale | 520.01 - 657.29 | 3.52k | - |
| 2025-10-29 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | 972.00 | 540.11k | Derivative Exercise and Retained Stock | 555.67 | 54.42k | 1.82% |
| 2025-10-29 | Dr. Andrew J. MurphyExec. VP of Research & Co-Chief Scientific Officer | -34.03k | 2.17M | Derivative Exercise and Sale | 555.67 - 648.82 | 54.42k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
